The company that was established in 2019 has a highly qualified management team whose expertise ranges from product development in medical sector to investment and marketing.
Having developed a technology of using nanotechnology as a vector for initiating antigen antibody reactions it initially intended to use this technology in the diagnosis of COVID19 antigens and antibodies in a single cassette.
The company is exploring a completely new device design, this design of the cassette involves using microfluidics and can be graphically explained during a meeting. It would like to discuss the feasibility of the proposed design of the device.
The company is seeking to work with suitable partners under licensing, manufacturing or commercial agreement with technical assistance agreements.